跳至主要内容
临床试验/ACTRN12619001556134
ACTRN12619001556134招募中未知

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke (OPTIMISTmain): An international, stepped-wedge, cluster randomised clinical trial to determine whether less-intense monitoring is at least as effective (‘non-inferior’) to standard monitoring in the functional recovery of ischaemic stroke patients.

The George Institute for Global Health0 个研究点目标入组 7,200 人开始时间: 2019年11月12日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
7,200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adults (age more than 18 years);
  • Diagnosis of AIS and have been given intravenous (IV) bolus infusion of rtPA;
  • Clinically stable with mild-moderate neurological deficit (e.g. National Institutes of Health Stroke Scale [NIHSS] score less than 10) within 2 hours post IV tPA bolus dose in the opinion of the treating clinician
  • Provide informed consent (or via an appropriate proxy, according to local requirements) and remain in follow-up for 90 days

排除标准

  • Definite contraindication for less intense monitoring, in the opinion of the treating clinician( i.e needs monitoring of co-morbid conditions such as renal failure, palliative care, ICU admission);
  • Immediate transfer for medical treatment (e.g. for haemodialysis) or surgery (e.g. carotid endarterectomy, hematoma evacuation) where adherence to less-intense monitoring is not possible.

研究者

相似试验